Mitsubishi UFJ Capital, established in 1974, is a Tokyo-based venture capital firm. It invests in early-stage companies, primarily in the Japanese market, focusing on sectors such as healthcare, biotech, information technology, and electronics. The firm also engages in investment syndication for Japanese deals. Mitsubishi UFJ Capital was previously known as Diamond Capital.
Manabie International Ltd., established in 2019 and headquartered in Singapore, specializes in online and offline education services for students from elementary to high school levels. The company offers a learning software suite, Manabie Basic and Manabie Prime, which includes online classes, mock exams, and live tutoring. Additionally, Manabie Hub provides offline education services, such as one-on-one personal coaching. Manabie's mission is to innovate learning by integrating online and offline resources, providing students with high-quality materials, personalized coaching, and efficient learning environments.
Linqmed
Series B in 2025
Developer of radiopharmaceuticals intended to offer treatment of cancer. The company engages in the research and development of therapeutic and diagnostic drugs for cancer using 64Cu which is a radioisotope of copper, enabling doctors to provide cancer treatments to the patients.
FactBase
Series B in 2025
FactBase is a company focused on enhancing the visibility of small and medium-sized enterprises that contribute to Japan's manufacturing sector. It has developed a cloud-based drawing management system designed to integrate drawings with various data types, facilitating centralized management. The platform includes features such as multi-axis drawing search, linking and central management, and project management capabilities tied to drawings. This system aims to improve the efficiency of complex drawing management processes, allowing users to easily upload and organize their data. By offering these tools, FactBase supports businesses in optimizing their operational workflows and enhancing their productivity in the manufacturing arena.
Ababa
Series B in 2025
Ababa is a recruitment solutions provider that connects job seekers with potential employers through an innovative platform. The company facilitates the job search by allowing firms to recommend graduate students who may have been overlooked due to issues such as cultural fit or personnel reductions during the hiring process. This approach enables companies to share candidates with others, thereby increasing employment opportunities for students. By leveraging insights from competing firms, Ababa aims to enhance the recruitment experience for both job seekers and employers, ultimately supporting successful career placements.
Logiless
Series B in 2025
Logiless is a cloud-based software solution designed for e-commerce businesses, focusing on integrated management of orders and inventory. The platform automates various aspects of the e-commerce workflow, from order placement to shipping, thereby reducing the need for manual intervention. By streamlining operations, it enhances efficiency while keeping costs low. This comprehensive tool allows warehouse operators to improve productivity and enables businesses to manage their inventory and orders in a cohesive manner, facilitating faster shipping and overall operational effectiveness.
Kamereo
Series B in 2024
Kamereo is a B2B distributor specializing in the food and beverage industry, utilizing technology to enhance the supply chain process for restaurants. The company provides a comprehensive marketplace that connects restaurants with suppliers, streamlining the purchasing and sourcing experience. With an emphasis on competitive pricing and user-friendly order management, Kamereo's platform allows businesses to efficiently track and analyze their orders. By simplifying the supply chain, Kamereo enables F&B store owners to save both time and money while prioritizing customer satisfaction.
NEL
Series B in 2024
NEL is a creative agency that connects brands with customers through purchases and social media interactions. The agency specializes in marketing planning and distribution, leveraging creators on short movie platforms to enhance brand visibility and engagement. By focusing on individual aesthetics, NEL aims to transform creative expressions into economic value, supporting both creators and brands in their growth and monetization efforts.
Plott
Series B in 2024
Plott Inc. is a Tokyo-based company that specializes in the production and distribution of original IP content on YouTube, particularly focusing on animation. Founded in 2017 and initially named Fabo, the company rebranded to Plott in 2019, reflecting its commitment to storytelling and content creation. Plott develops data-driven animations by analyzing viewer behavior to enhance engagement and growth. The company fosters collaborations with existing channels to increase subscriber numbers and promote cross-viewership, ensuring a steady stream of original content for audiences. Its vision is to establish itself as a prominent content holder within the YouTube ecosystem, continuously delivering innovative and engaging animations.
Tacoms
Series B in 2024
CAMEL is a restaurant management software firm that operates in managing orders from numerous ordering sources. This service allows you to handle several delivery and takeout services on a single terminal, from ordering to totalling.
REJECT
Series B in 2024
REJECT is an esports and entertainment organization that specializes in the management and operation of professional esports teams. Founded in 2018 and based in Minato, Japan, REJECT focuses on fostering communication and creativity within the esports community. The organization provides comprehensive team management services, which include the planning and execution of campaigns, events, and exhibitions. By combining esports with cultural elements, REJECT aims to enhance the domestic esports market and elevate players to national prominence, bridging gaps across various demographics and fostering inclusivity.
Simple Form
Series B in 2024
Simple Form provides real-time information on all domestic corporations necessary for financial institutions. We will accelerate the time-consuming and labor-intensive research work of corporations and take on the role of new financial underpinnings.
Rege Nephro
Series B in 2024
Rege Nephro Co., Ltd., established in 2019 and based in Kyoto, Japan, is a biotech company focused on the research, development, production, and marketing of therapeutics for renal diseases. The company leverages induced pluripotent stem cell (iPSC) technology, sourced from the Center for iPS Cell Research and Application at Kyoto University, to create innovative treatments for kidney, liver, and pancreas conditions. Rege Nephro develops drugs that utilize core seeds technology, which includes pluripotent stem cells capable of producing erythropoietin (EPO) and specific nephron progenitor cell markers. This approach aims to minimize the reliance on dialysis among patients with renal failure by offering effective therapeutic alternatives. Additionally, the company produces kidney organoids designed for nephrotoxicity screening, facilitating drug discovery in applied research.
GITAI
Series B in 2024
GITAI Inc. is a leading space robotics company based in Tokyo, Japan, established in 2016. The firm specializes in manufacturing humanoid telepresence robots to assist with tasks related to space exploration, particularly within space stations and lunar development. GITAI's product lineup includes the G1 robot, designed for general-purpose automation, the S1 robot for specific task automation, and the H1 manipulation system for remote operation of robots in space. By providing a reliable alternative to human labor, GITAI aims to enhance safety, improve efficiency, and significantly reduce operational costs in space activities. Their technology is intended to facilitate the construction and maintenance of satellites, space stations, and future habitats on the Moon and Mars, ultimately enabling more sustainable and cost-effective space exploration.
TriOrb
Series B in 2024
Triorb is a technology company focused on advancing robot mobility through innovative software and hardware solutions. It specializes in developing robotic technologies aimed at enhancing efficiency and safety within manufacturing environments. Triorb's movement system integrates a ball-driven omnidirectional mechanism with coordinated movement capabilities, enabling robots to transport various objects that cannot be handled by a single unit. This cooperative transportation system allows multiple robots to work together, improving operational effectiveness for businesses in need of automated solutions.
Jubo
Series B in 2024
Jubo is Asia's largest tech company dedicated to the often-overlooked market of senior care. With a great passion for creating a better person-centered care environment and next-gen aging life, Jubo has been developing holistic solutions and software systems via a team of multidisciplinary experts in mobile technology, user experience research, data science, and spatial design. Since 2019, Jubo has served 700 healthcare institutions, 40,000 residents, and 3,000 care professionals, while simultaneously 600 millions of data points. Jubo has been internationally recognized with awards and honors in innovation, technology, design, and business, and continues to deepen its technology capability with many more registered patents worldwide. Headquartered in Taipei, Jubo is now expanding across Asia Pacific and the North America region.
Aeterlink
Series B in 2024
Aeterlink is a developer of advanced wireless power transfer technology aimed at eliminating the need for wires in various applications. The company specializes in creating wireless devices that can be applied across multiple fields, including factory automation, robotics, smart homes, and medicine. By enabling the wireless transmission of power over distances, Aeterlink's innovations enhance efficiency, sustainability, and safety in industries, allowing for greater flexibility in device placement and reducing the risks associated with traditional wiring. Their technology represents a significant step toward a digital world that operates without the constraints of physical connections.
aceRNA Technologies
Series B in 2024
aceRNA Technologies is a biotechnology startup focused on developing innovative genetic therapies utilizing RNA switch technology. The company specializes in regenerative medicine, aiming to discover novel functions of microRNAs (miRNAs) that can regulate gene expression. By harnessing this technology, aceRNA Technologies seeks to facilitate the removal of undifferentiated and potentially cancerous cells, thereby enhancing drug discovery and therapeutic applications. Through its patient-centric approach, the company strives to advance the field of genetic therapies and improve treatment outcomes in various medical conditions.
enechain
Series B in 2024
Enechain is a company focused on providing solar energy solutions through an innovative energy marketplace platform. This platform facilitates the trading of energy products by offering a price discovery function that helps users visualize fair market prices. Additionally, Enechain includes a distribution function that finalizes transactions and ensures the delivery of products based on these fair prices. By enabling users to efficiently buy and sell various energy products, Enechain aims to enhance transparency and accessibility in the energy market.
ATOMica
Series B in 2024
ATOMica Co. Ltd. is a company based in Miyazaki Prefecture, Japan, founded in 2019. The firm specializes in the planning, management, and expansion of co-working spaces and shared kitchen-cafe facilities. ATOMica provides versatile office space services that cater to various needs, including workspaces, conference rooms, event venues, and educational gatherings. By focusing on maximizing individual potential within collaborative environments, the company enables easy access to innovative spaces tailored to diverse requirements. Additionally, ATOMica offers event planning and management services to enhance the experience and functionality of its facilities.
Emulsion Flow Technologies
Series B in 2024
Emulsion Flow Technologies is an environmental management company focused on rare metal recycling and the separation and purification of substances. The company has developed a solvent extraction method that aims to enhance the efficiency of these processes. By offering advanced technology tailored for the rare metal recycling industry, Emulsion Flow Technologies enables businesses to improve productivity, enhance the working environment, and increase both separation and purification capacities. Additionally, their innovations contribute to reducing the environmental impact associated with these operations.
Biophilia
Series B in 2024
Biophilia Inc., founded in August 2017 and located in Shibuya-ku, Tokyo, specializes in creating and delivering high-quality dog food. The company focuses on producing fresh, natural, and handmade dog food that adheres to stringent nutritional standards and is supervised by veterinarians. Biophilia sources fresh domestic meat and vegetables to ensure the food retains its aroma, color, and nutritional value. In addition to its core business of pet food production, Biophilia also engages in consulting, internet services, and consignment development related to pet care. Through its commitment to quality, Biophilia aims to provide dogs with suitable and nutritious food options.
Trinity Technology
Series B in 2024
Trinity Technology is technology company that provides services related to asset protection and inheritance planning.
Xbit
Venture Round in 2024
Xbit provides a shift management system that assists shop owners in optimizing their business processes. The company's platform includes a chatbot service that enables users to gather employee availability and create efficient shift schedules. By addressing customer needs and implementing effective solutions, Xbit helps clients reduce operational costs while maintaining service quality through proper personnel allocation.
Micoworks
Series B in 2023
Micoworks is a planning and development platform that focuses on enhancing marketing strategies through improved communication. It offers tools designed for optimal communication and personalization of the customer experience. The platform enables businesses to categorize customer information effectively and automates various processes, including customer interviews, conversations, and reservations. This functionality allows clients to streamline their operations and develop their marketing strategies more efficiently.
Hydro Powtech Japan
Series B in 2023
Nippon Hydropowtech specializes in innovative food processing technology that focuses on shortening the food fermentation process while avoiding chemical additives. The company employs proprietary technology and extensive experience in hydrolyzate production to create both powder and liquid raw materials that effectively break molecular bonds in dietary fiber, carbohydrates, and proteins. This process reduces molecular weight, allowing clients to efficiently brew and ferment food products with minimal environmental impact and reduced energy consumption. Additionally, Nippon Hydropowtech explores new food applications, leveraging its advancements to enhance the overall quality and sustainability of food production.
ACALL
Series B in 2023
Acall offers a Smart Office platform that aims to create safe, secure, and comfortable work environments for users, regardless of location. Utilizing artificial intelligence and the Internet of Things, the platform automates and enhances workplace experiences, allowing for seamless management of employees and conference spaces. By facilitating a balanced integration of office and remote work, Acall enables individuals and organizations to design their workspaces according to their specific needs, fostering productivity and flexibility in various work settings.
Lilz
Series B in 2023
LiLz is a technology startup focused on enhancing fieldwork operations through the integration of machine learning and Internet of Things (IoT) technologies. The company has developed the LiLz Gauge, a low-power IoT camera that captures and analyzes data from analog meters, which can operate similarly to smart meters. By uploading images to the cloud, the system employs character and image recognition to streamline the monitoring process. Additionally, LiLz is advancing a sound search service, known as LiLz Sound Search, designed to detect abnormalities in equipment, further improving operational efficiency for clients. This innovative approach allows organizations to reduce on-site work while increasing productivity and accuracy in their operations.
GITAI
Series B in 2023
GITAI Inc. is a leading space robotics company based in Tokyo, Japan, established in 2016. The firm specializes in manufacturing humanoid telepresence robots to assist with tasks related to space exploration, particularly within space stations and lunar development. GITAI's product lineup includes the G1 robot, designed for general-purpose automation, the S1 robot for specific task automation, and the H1 manipulation system for remote operation of robots in space. By providing a reliable alternative to human labor, GITAI aims to enhance safety, improve efficiency, and significantly reduce operational costs in space activities. Their technology is intended to facilitate the construction and maintenance of satellites, space stations, and future habitats on the Moon and Mars, ultimately enabling more sustainable and cost-effective space exploration.
Techtouch
Series B in 2023
Techtouch, Inc. is a Tokyo-based company founded in 2018 that specializes in developing TechTouch, a digital transformation platform designed to improve operational efficiency for businesses. Its software provides an intuitive website user manual by overlaying explanatory guidance directly onto existing web systems through a browser plug-in and server-side integration. This approach allows for real-time navigation assistance, minimizing the challenges associated with complex system operations. By enhancing system education for employees and promoting better utilization of web resources, Techtouch aims to reduce operational burdens and streamline business processes.
Regional Fish
Series B in 2022
Regional Fish Inc., founded in 2019 and based in Kyoto, Japan, specializes in the development of advanced breeding technologies for fish using genome editing and artificial intelligence. The company focuses on creating sustainable land-based aquaculture systems that minimize environmental impact, utilizing clean energy and organic waste nitrogen. By leveraging high-speed breeding techniques, Regional Fish aims to enhance the efficiency of the fisheries industry while promoting natural evolution. Through its innovative approach, the company seeks to transform the aquatic industry and provide consumers with genome-edited food options.
MOON-X
Series B in 2022
MOON-X Inc., founded in 2019 and based in Tokyo, Japan, operates under its brand CRAFT X, producing and selling craft beer. The company focuses on enriching lives through co-creation with communities and manufacturing partners, offering a diverse range of products across various categories. In addition to craft beer, MOON-X's product lineup includes men's and women's skincare, baby and maternity items, leather accessories, and business goods. By serving as a launch pad for brands, MOON-X aims to deliver innovative consumer products that cater to the needs of its clientele.
Aculys Pharma
Series B in 2022
Aculys Pharma is a pharmaceutical company that develops drugs and innovative medical treatments for neurological and psychiatric disorders.
QunaSys
Series B in 2022
QunaSys is a developer of software focused on algorithm and application development to advance the practical use of quantum technology. The company aims to harness quantum properties to create technologies that traditional methods cannot achieve. Its platform simulates phenomena related to the quantum mechanical behavior of electrons and atomic nuclei, facilitating the execution of quantum chemistry calculation algorithms on both quantum computers and simulators. By bridging the gap between theoretical quantum physics and practical applications, QunaSys seeks to bring quantum technologies to the forefront, enabling researchers to effectively explore and utilize these advanced capabilities.
Infostellar
Series B in 2021
Infostellar Inc., founded in 2016 and based in Tokyo, Japan, specializes in developing cloud-based communication solutions for satellite operators. The company offers StellarStation, a modular platform that allows ground station owners to monetize their surplus capacity while enabling satellite operators to connect with satellites using a diverse range of antennas globally, all through a single interface. By facilitating the sharing of satellite antennas during idle periods, Infostellar helps reduce operational costs and enhance transmission time, thereby improving the quality of service for satellite operators. Additionally, Infostellar provides tools such as Ground Station Search and Makesat, further streamlining the satellite communication process.
Spider Labs
Series B in 2021
Spider Labs, Ltd. is a cybersecurity company based in Tokyo, Japan, specializing in the detection and prevention of online advertising fraud. Founded in 2011, the company develops an automated, AI-driven software known as Spider AF, which safeguards digital advertisements from fraudulent clicks and conversions. This tool enables ad tech businesses, advertisers, and ad agencies to effectively identify and block fraudulent activities through centralized fraud management and advanced analytics. By providing complete transparency in digital advertising, Spider Labs enables clients to track ad placement, recognize fraudulent behaviors, and access clean, fraud-free data, thereby enhancing the integrity of online advertising campaigns.
Luxonus
Series B in 2021
Luxonus is a medical device manufacturing company specializing in photoacoustic technology aimed at early disease detection and diagnosis. The company has developed an advanced imaging device that utilizes optical ultrasonic technology, which combines light and ultrasonic waves to create ultra-high-resolution three-dimensional images of blood vessels and lymphatic vessels. This innovative approach allows for safe and easy imaging without exposure, providing healthcare professionals with a comprehensive understanding of disease onset, healing processes, and overall health conditions before and after illness.
GexVal
Series B in 2021
GEXVal Inc. is a drug discovery company based in Fujisawa, Japan, founded in 2018. The company focuses on the research and development of innovative treatments for rare and incurable diseases, particularly in the fields of psychiatry, neurology, and pulmonary arterial hypertension. GEXVal aims to enhance the health and quality of life for patients and families affected by these challenging conditions by providing cost-effective treatment options. Through its commitment to addressing the needs of those with intractable diseases, GEXVal strives to make a meaningful impact in the realm of healthcare.
Parallel
Series B in 2021
Parallel is a virtual hangout platform that allows sharing content with friends. On the social networking site Parallel, users can enjoy a variety of content while chatting with their close friends. It enables the creation of a room where anyone who has been invited may enter and can immediately begin speaking.
GiXo
Venture Round in 2021
GiXo Ltd. is a consulting firm based in Tokyo, Japan, that specializes in marketing services powered by technology and big data. Founded in 2012, the company focuses on providing analysis support to help clients address business challenges. By leveraging data analytics, GiXo assists organizations in resolving management issues and making informed, data-driven decisions. The firm was established by strategists and analytics experts dedicated to enhancing business performance through innovative solutions.
JCG
Series B in 2021
JCG specializes in e-sports tournament planning and management, providing services that encompass community engagement, promotion, and recreational activities. The company organizes both online and offline competitions, utilizing a user-friendly web system supported by cloud technology and its own distribution studio. This approach enables JCG to assist clients in developing and enhancing e-sports infrastructure effectively.
DAIZ
Series B in 2021
DAIZ Inc., founded in 2015 and based in Kumamoto, Japan, specializes in the production and supply of plant-based meat products, notably under the brand name 'Miracle Meat.' Utilizing a proprietary process known as the 'Ochiai Germination Method,' the company transforms germinated soybeans into functional food substances that serve as healthy, plant-based alternatives to traditional meat. In addition to its production activities, DAIZ is involved in research and development focused on raw materials and drug discovery derived from germinated soybeans, further emphasizing its commitment to innovation in the plant-based food sector.
unilabo
Series B in 2020
Unilabo, Inc. operates a business-to-business (B2B) ordering platform based in Tokyo, Japan, founded in 2012. The company specializes in a supplier search service that provides detailed information on suppliers, subcontractors, and outsourcing companies. This service highlights the characteristics, achievements, and offerings of these entities, which are often difficult to discover through traditional search methods. Unilabo's platform, known as Aimitsu, enables users to compare service information and pricing across various sectors, including IT and information systems, sales and marketing, back office operations, and overseas expansion. This comprehensive approach supports businesses in making informed decisions when selecting suppliers and partners.
Japan Data Science Consortium
Series B in 2020
Japan Data Science Consortium Co. is a Tokyo-based company specializing in artificial intelligence, the Internet of Things, and robotics. Founded in 2014, it offers a range of services including demand forecasting, predictive maintenance, digital transformation, optical character recognition, and image recognition. The company focuses on providing solutions tailored to the medical, education, and retail sectors, aiming to facilitate significant profit impact through comprehensive consulting. JDSC supports clients from system construction to corporate process transformation, ensuring the effective integration of AI technologies into their operations.
Periotherapia
Series B in 2020
Periotherapia is a drug discovery company focused on developing targeted medical treatments for intractable diseases, with a particular emphasis on triple negative breast cancer as its primary indication. The company aims to selectively inhibit specific disease-related pathways, notably the ASV involved in disease pathogenesis, while preserving the physiological functions of ASV in chronic conditions such as cancer, heart failure, arteriosclerosis, renal failure, and diabetic retinopathy. By utilizing disease-specific antibodies, Periotherapia contributes to early diagnosis and precision medicine through companion diagnostics, thereby enhancing the ability of healthcare professionals to discover new therapeutic options for these challenging diseases.
Social Interior
Series B in 2020
Social Interior is a furniture design platform that specializes in subscription services for new furniture and home appliances. The company aims to promote a sustainable lifestyle by offering a diverse range of furniture for rent, including chairs, tables, sofas, and kitchen storage. Through its online platform, customers can conveniently book sustainable furniture for specific periods, aligning with the company's goal of fostering a recycling society that values long-lasting products. Social Interior's services cater to the growing demand for flexible and eco-friendly home furnishing options.
CellAxia
Series B in 2020
CellAxia Inc., founded in 2017 and based in Tokyo, Japan, is a biotechnology startup focused on developing cell therapy drugs. The company aims to transform advanced research into practical applications in the healthcare sector, specifically targeting intractable autoimmune diseases. CellAxia specializes in the discovery, development, and commercialization of biological therapies, enabling researchers to utilize challenging cell types, such as primary and cancer stem cell cultures. Through its innovative approach, CellAxia seeks to create new therapeutic cell-based treatments, addressing unmet medical needs in the field of cell therapy.
LegalForce
Series B in 2020
LegalForce, Inc., founded in 2017 and headquartered in Toyosu, Tokyo, Japan, specializes in developing and maintaining AI-powered software for legal services, particularly in contract management. The platform employs natural language processing and other advanced technologies to assist legal professionals by reviewing contracts based on their type, identifying potentially omitted or risky clauses, and minimizing oversights. This functionality aims to enhance the quality and efficiency of legal operations, providing valuable support in the contract review process.
Roxx
Series B in 2020
ROXX Inc. is a Tokyo-based company that specializes in job placement services for musicians. Founded in 2013 and formerly known as Scouter Inc. until a name change in July 2019, ROXX provides a platform designed to help recruit inexperienced full-time employees in the music industry. The company offers various products, including Back Check, a reference check service, and SARDINE, a cloud-based job database. Through its innovative features focused on reference compliance and research tools, ROXX seeks to streamline the hiring process for musicians and related talent.
LegalOn Technologies
Series B in 2020
LegalOn Technologies is a global leader in AI contract review, assisting over 5,000 companies and law firms in enhancing their contract negotiation processes by making them faster and more accurate. Founded in 2017, the company leverages artificial intelligence combined with the expertise of experienced attorneys to identify risks within contracts and support various contract-related operations. LegalOn's platform enables legal and business teams to save time, reduce legal risks, and escape tedious tasks, allowing them to focus on more strategic aspects of their work. The software offers customizable playbooks, streamlines contract search and storage, and provides an AI assistant for real-time contract inquiries, both online and integrated within Microsoft Word. With significant backing from prominent investors, LegalOn operates on a global scale, particularly in the US and Japan, delivering immediate value to its users through its comprehensive AI contract review solution.
ArchiTek
Series B in 2020
ArchiTek is a hardware manufacturing company that focuses on the development of circuit designs for embedded systems. The company specializes in creating artificial intelligence and image-processing digital circuits that enhance the efficiency of data storage, processing, and analysis. ArchiTek's circuits enable computers to sense and interpret their environments in dynamic conditions, offering clients affordable and high-performance AI chips tailored for embedded applications.
LINK-US
Series B in 2020
LINK-US Co., Ltd., established in 2014 and headquartered in Yokohama, Japan, specializes in the development and manufacturing of ultrasonic complex vibration bonding equipment. The company's core business involves designing and producing bonding equipment that utilizes ultrasonic compound vibration technology, catering to a diverse range of similar and dissimilar metal materials. LINK-US also engages in contract sales of devices employing this advanced technology.
Numab
Series B in 2019
Numab is a biotechnology company focused on developing antibody-based therapies for severe diseases like chronic inflammation and cancer. Its proprietary platform streamlines the discovery process by reducing randomness, predictably generating ready-to-develop multispecific biotherapeutics tailored to engage multiple targets simultaneously. This enables healthcare industries to access Numab's platform for innovative treatments in these areas.
Funds
Series B in 2019
Funds is a loan investment firm that specializes in facilitating financing for businesses through an online peer-to-peer lending marketplace. The company connects individual investors with businesses seeking operating capital, allowing these investors to manage their assets and invest in financial instruments that offer moderate risk and returns. Through silent partnership agreements, Funds enables companies to invest in financing options in small increments, making it accessible for a wider range of investors and businesses. This model not only supports businesses in obtaining necessary funds but also provides a platform for individuals to participate in the lending process.
Crowdport
Venture Round in 2019
Crowdport operates “Funds,” a P2P platform, connecting individual investors who wish to manage their assets with companies that wish to borrow operating funds.
Atmoph
Series B in 2019
Atmoph Inc., founded in 2014 and based in Kyoto, Japan, specializes in the development of Atmoph Window, a smart digital window that provides immersive experiences by displaying 4K videos and sounds of scenic locations from around the globe. This innovative product aims to transform the way individuals engage with nature and information at home, enhancing their quality of life. By offering a diverse selection of visual and auditory landscapes, Atmoph Window enables users to create a tranquil and enjoyable environment, effectively bringing the beauty of the outdoors into their living spaces.
Araya
Series B in 2019
Araya Inc. is a Tokyo-based company that specializes in developing artificial intelligence software solutions. Founded in 2013, the company focuses on deep learning algorithms that facilitate real-time image recognition and processing services, enabling the identification of various individuals and objects in images and videos. Araya's technology also includes deep reinforcement learning, allowing for the autonomous movement of drones and robots. Additionally, the company has developed a unique deep learning compression technology that enhances the efficiency of its algorithms, making them smaller and faster while maintaining accuracy. By aiming to advance the capabilities of artificial intelligence towards potential artificial consciousness, Araya seeks to address the diverse needs of its clients through innovative AI services.
Kyash
Series B in 2019
Kyash Inc. is a Japanese fintech startup founded in 2015 and headquartered in Tokyo. The company develops a mobile wallet application and payment platform that enables users to make payments at Visa merchants and conduct peer-to-peer transfers. Kyash offers a proprietary technology platform that allows businesses to issue their own Visa cards instantly through APIs, enhancing their payment processing capabilities. The services provided by Kyash include sending and requesting money quickly and securely using virtual and prepaid cards, making it a convenient option for users seeking efficient money transfer solutions.
Kyulux
Series B in 2019
Kyulux, Inc. is a Japanese company specializing in the research and development of organic electroluminescent materials for organic light-emitting diode (OLED) displays and lighting solutions. Founded in 2015 and based in Fukuoka, Kyulux is a leader in the advancement of thermally activated delayed fluorescence (TADF) technology, which enhances the efficiency of OLED emission. The company offers innovative products, including its proprietary Hyperfluorescence solution, which combines TADF and fluorescence emitters. This technology enables manufacturers in the display and lighting industries to produce cost-effective, durable, and efficient OLED solutions without relying on rare metals. With a significant intellectual property portfolio developed at Kyushu University and in collaboration with industrial partners, Kyulux is positioned at the forefront of the OLED technology market.
Div
Venture Round in 2019
DIV Inc., founded in 2012 and based in Tokyo, Japan, specializes in offering programming courses and training programs. The company operates TECH::CAMP, a programming school that provides short-term intensive training designed to transform students into skilled engineers. DIV's programming schools are available in both online and classroom formats, catering to individuals looking to transition from inexperienced workers to professional engineers. This approach not only equips students with essential programming skills but also enhances their employability in the technology sector, particularly as web designers.
Holoeyes
Series B in 2019
HoloEyes Inc. is a Tokyo-based company founded in 2016 that specializes in developing virtual reality applications for the medical field. The company's platform allows healthcare professionals to transform CT scan data into three-dimensional images, facilitating better visualization and understanding of medical conditions. By creating a medical VR database from accumulated 3D human body models, HoloEyes aims to enhance surgical planning and diagnosis. The technology enables surgeons to simulate operations in a virtual environment, improving their ability to prepare for complex procedures. HoloEyes is focused on expanding its business and increasing its workforce to further develop its innovative VR healthcare solutions.
Trustdock
Series B in 2019
Trustdock Inc., founded in 2017 and based in Tokyo, Japan, specializes in identity verification solutions. The company offers an identity confirmation platform that provides an API service for Know Your Customer (KYC) processes, allowing businesses to outsource identity verification efficiently. Trustdock's platform complies with various Japanese laws, including those related to criminal profit transfer prevention and fraud prevention. It supports a wide range of applications, making it suitable for diverse sectors such as FinTech and shared economy services. By facilitating individual identity confirmation, personal number acquisition, and risk assessments, Trustdock enables individuals and businesses to authenticate digital identities in a convenient manner, fostering trusted business relationships and transactions.
Chordia Therapeutics
Series B in 2019
Chordia Therapeutics Inc. is a clinical-stage biotechnology company based in Fujisawa, Japan, founded in 2017. The company focuses on the research and development of innovative oncology drugs aimed at addressing significant unmet medical needs in cancer treatment. Chordia Therapeutics is dedicated to delivering first-in-class therapeutic options to patients, emphasizing the importance of advancing cancer care through its specialized bioventure efforts.
ProteanTecs
Series B in 2019
ProteanTecs Ltd. is a software company that specializes in a cloud-based platform designed to enhance the performance and reliability of electronic systems. Founded in 2017 and headquartered in Haifa, Israel, with additional offices in Tel Aviv, Santa Clara, and Bridgewater, the company utilizes data generated by chip-embedded agents and machine learning to predict faults before they lead to failures. Its solutions deliver valuable insights across the entire value chain, benefiting chip vendors, system vendors, and digital service providers. ProteanTecs offers various capabilities, including predictive maintenance, yield improvement, and performance tuning, aimed at reducing defect parts per million (DPPM) and enhancing overall electronic performance and quality.
Veritas In Silico
Venture Round in 2019
Veritas In Silico Inc., founded in 2016 and based in Tokyo, Japan, specializes in drug discovery focused on medium and small molecules, particularly those targeting messenger RNA (mRNA). Utilizing its proprietary ibVIS platform, the company integrates informatics with experimental biology to develop mRNA-targeted drugs, including small molecules and antisense oligonucleotides. Veritas In Silico aims to address unmet medical needs by providing effective treatments for diseases that currently have limited therapeutic options.
naturacart
Venture Round in 2019
naturacart is a natural and organic CtoC / BtoC marketplace that sells products selected by buyers around the world and products from overseas brand manufacturers that have not yet arrived in Japan. The lineup ranges from beauty and health care products to wine, food and sportswear. The company sells products mainly for women, and is characterized by the ability to purchase foreign-made products that are not yet available in Japan. We have high-quality products carefully selected by manufacturers, distributors, shops and buyers in about 50 countries around the world.
Modulim
Series B in 2019
Modulim is a leader in light-based imaging technology focused on tissue and vascular assessment through spatial frequency domain imaging (SFDI). The company has developed the Clarifi Imaging System, which aids clinicians in identifying patients at risk for complications such as diabetic foot ulcers and amputations due to compromised circulation. By enabling timely interventions, this technology plays a crucial role in preserving patients' limbs and lives. Additionally, Modulim's devices are applicable in research, aesthetics, and medicine, providing professionals with transformative tools for the prevention, diagnosis, and treatment of various medical skin conditions.
Cart
Series B in 2019
Cart Ltd. is a Tokyo-based company founded in 2016 that operates Naturacart, an online platform specializing in the sale of natural and organic products. The platform offers a diverse range of items, including wine, diapers, beauty care products, oils, spices, breads, dairy products, supplements, stationery, and toiletries. Cart enables consumers in Japan to access wellness products sourced from around the globe, catering to the growing demand for health-conscious and environmentally friendly options.
Ball Wave
Series B in 2018
Ball Wave Inc. specializes in the development, manufacturing, and sale of advanced sensors, including trance moisture sensors, mini sensors, and ball surface acoustic wave gas sensors. Founded in 2015 and based in Sendai, Japan, the company focuses on innovative sensor technology that enables high-speed and sensitive detection of various chemical attributes, such as moisture and hydrogen, at the nanoscale. Their spherical sensors and analyzers serve as essential tools for accurately monitoring environmental conditions, effectively functioning as an advanced detection system for a range of gases and materials.
Uncover Truth
Venture Round in 2018
Uncover Truth is an analytics company that specializes in providing data visualization and content analytics services accessible through web and mobile platforms. The company develops tools designed to analyze customer behavior on websites using both quantitative and qualitative data. These tools include form analysis, session playback, and click heatmaps, which help identify user behaviors and pinpoint issues with the user experience. By offering these insights, Uncover Truth enables website operators to better understand their customers and enhance their websites accordingly.
Hmcomm
Series B in 2018
Hmcomm Co. Ltd., established in 2012 and headquartered in Tokyo, Japan, specializes in developing and providing AI-driven voice recognition solutions. The company's core business involves creating a cloud-based platform for speech recognition, natural language processing, and automatic summarization. Hmcomm serves a diverse range of clients, including government agencies, financial institutions, and IoT and robotics companies, offering services such as speech recognition engine development, IoT device-oriented FOTA/IoT systems, and abnormal sound detection. With additional offices in China and India, Hmcomm aims to enhance business efficiency through its innovative voice recognition and processing technologies.
sitateru
Series B in 2018
Sitateru is a product manufacturing platform that supports garment brands throughout the entire process, from product planning to production and delivery. It connects independent fashion brands and retailers with garment factories, facilitating their clothing production needs. By establishing a network among these entities, Sitateru enables clients to explore expansion opportunities and streamline their operations in the clothing industry. This tailor-controlled system enhances the efficiency of production while catering to the specific requirements of clothing companies.
CureApp
Series B in 2018
CureApp, Inc., founded in 2014 and based in Tokyo, Japan, specializes in developing mobile applications aimed at treating various health conditions, particularly nicotine addiction. The company's flagship product, a nicotine addiction treatment app, was launched in February 2015 in collaboration with the Division of Pulmonary Medicine at Keio University’s School of Medicine. CureApp is recognized as a prominent player in the digital health sector, focusing on applications that exhibit therapeutic effects against diseases. The company is actively conducting clinical trials to validate the efficacy of its applications. Additionally, CureApp's medical treatment platform allows users to keep daily activity logs, which are analyzed to identify triggers exacerbating their conditions. This technology enables patients to receive personalized guidance in managing lifestyle diseases, addressing health issues that are typically not managed by conventional medications or devices.
Stem Cell & Device Laboratory
Series B in 2017
Stem Cell & Device Laboratory, Inc. focuses on research and development, manufacturing, and sales of cellular products, devices, and integrated cell-material products specifically designed for drug discovery applications. The company specializes in creating innovative scaffold materials that enhance cell functionality and compatibility, leveraging advanced micro-engineering and nanofabrication technologies. Founded in 2014 and headquartered in Kyoto, Japan, Stem Cell & Device Laboratory is dedicated to advancing cell applications that contribute to a healthier society.
toBe marketing
Series B in 2017
toBe Marketing Co., Ltd., established in 2015 and based in Tokyo, Japan, specializes in marketing automation and client management system services. The company offers consulting and introduction services for various marketing tools, including social media collaboration, email distribution, and salesforce integration. Their mission is to enhance client engagement and drive sales growth by streamlining marketing and sales activities through digital technology.
DiscGenics
Series B in 2017
DiscGenics, Inc. is a clinical-stage biotechnology company focused on developing cell-based regenerative therapies specifically for degenerative diseases of the spine, particularly those affecting the intervertebral disc. The company utilizes allogeneic therapeutic progenitor cells derived from intervertebral disc tissue to create an injectable, homologous cell therapy. This innovative approach aims to provide a non-surgical alternative that alleviates pain and restores function in patients suffering from conditions related to the intervertebral disc. DiscGenics employs its tissue engineering platform technology to offer a promising solution to the limitations of current therapeutic options. Founded in 2007, the company is headquartered in Salt Lake City, Utah, and actively publishes scientific research to support its developments.
Capy
Series B in 2017
Capy Inc., established in 2010 and headquartered in San Francisco, specializes in web-based security solutions. It offers a CAPTCHA service that balances user experience with robust protection against automated abuse and spam. Capy's intuitive and simple CAPTCHA solutions aim to provide both ease of use and strong security, addressing the challenge of current security measures that are often either too complex or insufficiently secure. The company continually innovates to set new standards in online security.
Cellspect
Series B in 2017
Cellspect Co., Ltd, established in Japan in April 2014, specializes in the development, manufacturing, and sales of medical equipment. The company focuses on creating biomarker-sensing technology, transitioning from clinical to health tech markets. Its primary product line includes in-vitro diagnostic agents and medical devices designed to predict endometriosis progression. Cellspect aims to make medical treatment more accessible and improve diagnosis by developing point-of-care testing instruments and diagnostic agents, enabling real-time cloud-based results for prompt and appropriate patient consultations.
Floadia
Series B in 2017
Floadia Corporation, established in 2011 and headquartered in Tokyo, Japan, specializes in the development, licensing, and sale of semiconductor intellectual property, particularly focusing on embedded non-volatile memory solutions. The company leverages its engineering team's extensive experience in embedded FLASH technology, which includes contributions from pioneers in the field. Floadia's technology is designed for use in various applications, including Internet of Things devices, automobiles, smartphones, and smart cards. Their embedded memory solutions offer low-power consumption and cost efficiency, while also providing durability suitable for automotive-grade environments. In addition to its product offerings, Floadia provides technology consulting services to support its clients in optimizing their semiconductor needs.
SMARTCAMP
Series B in 2017
Smart Camp is a technology company that offers SaaS comparison services, inside sales agency support, and B2B digital marketing solutions.
Laxus Technologies
Series B in 2017
Laxus Technologies operates an online fashion-sharing platform that specializes in the rental of designer handbags. The platform enables users to borrow high-end handbags for an unlimited duration, with the option for free replacements. This service allows women to access luxury fashion items in a cost-effective manner, catering to individual preferences and budgets. Through its application, Laxus Technologies facilitates seamless transactions, allowing consumers to acquire goods directly from sellers via a web browser or mobile app.
PointGrab
Series B in 2016
PointGrab Ltd. specializes in machine learning technology for optical IoT devices designed for home and building automation. Founded in 2008 and based in Hod Hasharon, Israel, the company offers solutions such as PointSwitch, an optical module that transforms visual signals into actionable analytics. This technology provides essential features like occupancy sensing, ambient light detection, and behavioral analytics, enabling businesses to optimize real estate management, enhance efficiency, and reduce costs while ensuring employee privacy and welfare. PointGrab is recognized as a leader in the commercial real estate sector, integrating its optical sensors with connected systems for lighting, HVAC, safety, security, and access control, thereby delivering comprehensive insights into occupant usage within buildings.
WHILL
Series B in 2016
WHILL is a company that designs and manufactures personal mobility products suitable for both indoor and outdoor use, aiming to enhance transportation experiences for all individuals. Founded in 2013 and based in San Carlos, California, WHILL seeks to redefine the perception of mobility devices like wheelchairs and scooters through innovative technology and thoughtful design. In addition to creating and selling mobility vehicles, WHILL offers mobility-as-a-service, which includes autonomous transportation solutions and on-site fleet rentals. This service enhances accessibility in public spaces such as airports, hospitals, and tourist destinations, allowing users to navigate these environments without a driver's license and promoting a more independent lifestyle for wheelchair users.
HiBot
Series B in 2016
HiBot is a Tokyo-based company founded in 2004 that specializes in robotic systems and related hardware and software solutions. The company develops robotic platforms designed for hazardous operations, infrastructure maintenance and inspection, and search and rescue missions. HiBot offers robots as a service, providing clients with advanced systems that facilitate data acquisition, management, and real-time visualization. Their technology incorporates artificial intelligence for defect detection, allowing organizations to enhance safety by automating dangerous or repetitive tasks.
BitFlyer
Series B in 2015
BitFlyer, Inc. is a virtual currency exchange and blockchain development service provider based in Minato-ku, Japan. Established in 2014, it specializes in facilitating transactions in various digital currencies, including Bitcoin, Ethereum, and Litecoin, among others. BitFlyer offers a comprehensive platform that enables customers to buy, sell, and spend cryptocurrencies securely. It features multiple markets, including a Bitcoin marketplace and altcoin exchanges, along with advanced services such as an application programming interface for custom account management. Additionally, BitFlyer provides e-commerce payment solutions that allow businesses to accept Bitcoin, enhancing the overall trading experience. The company also operates fundFlyer, a crowdfunding platform designed to support projects through Bitcoin funding.
Megakaryon
Series B in 2015
Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.
Cyfuse Biomedical
Venture Round in 2015
Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.
Quantum Biosystems
Series B in 2015
Quantum Biosystems Inc. is a biotechnology company focused on the development of quantum bio sequencing technologies. Founded on January 7, 2013, and based in Yodogawa-ku, Japan, the company specializes in innovative single-molecule DNA and RNA sequencing systems designed for comprehensive genomic analysis. By applying principles of quantum mechanics, Quantum Biosystems aims to enhance the efficiency and accuracy of genetic data collection. Their systems facilitate accelerated DNA and RNA sequencing, enabling researchers to access and interpret genetic information more effectively. This technology promotes advancements in various fields of research, allowing clients to unlock complex genetic codes and further their scientific inquiries.
Retty
Series B in 2013
Retty Inc., established in Tokyo, Japan in 2010, operates a gourmet platform named Retty. This platform specializes in providing information about restaurants across Japan, with a focus on user-generated reviews and recommendations. It facilitates users to search for dining options based on store details and offers a social aspect by allowing individuals to share their restaurant experiences or plans with friends, making decision-making easier.
Muse
Series B in 2013
Muse & Co. Ltd. is a Tokyo-based online fashion retailer that specializes in women's clothing and accessories. Founded in 2012, the company targets young, professional women who seek high-quality fashion items. Muse & Co. employs a flash-sales business model, offering high-end brands at significant discounts to attract savvy shoppers. As of March 31, 2015, it operates as a subsidiary of Mixi, Inc. Through its platform, Muse & Co. aims to cater to the stylish preferences of its clientele while providing access to premium fashion at competitive prices.
Snapeee
Series B in 2013
Sequoia Capital is a venture capital firm that does seed, early stage venture, later stage venture, and private equity investments. It is focused primarily on companies engaged in developing mobile software and enterprise software. It is known as one of the highest-caliber venture firms, and one of Silicon Valley's most influential venture-capital firms by Wall Street Journal. It invests between 100,000 and $1 million in seed stage, between $1 million and $10 million in early stage, and between $10 million and $100 million in growth stage. Sequoia Capital has funded an unprecedented number of successful companies including Google, Yahoo, Paypal, Electronic Arts, NVIDIA, Cisco Systems, Oracle, Apple, YouTube, Admob and Zappos. It estimates that 19% of the NASDAQ's value is made up of firms they have funded. Sequoia Capital was established in November, 1972, based in Menlo Park, California. It was founded by Don Valentine. Currently it has offices in the U.S., China, India, and Israel.
Smart Education
Venture Round in 2012
Smart Education, Ltd., based in Tokyo, Japan, focuses on developing educational applications aimed at enhancing the learning experience for children. One of its flagship products is the "Rhythm Book," a music app available for smartphones and tablets that allows children to learn rhythm by tapping instruments along with popular songs and nursery rhymes in both English and Japanese. The app features over 100 songs, recorded in high-quality studio settings, to stimulate young minds. It is designed for interactive play between parents and children, fostering a collaborative learning environment. Users can purchase additional songs online, which can be shared across devices linked to the same Apple ID via iCloud. Through its innovative applications, Smart Education seeks to simplify the learning process and support children's intellectual development.
iPierian
Series B in 2010
iPierian is a biotechnology company specializing in the development of therapies for neurodegenerative diseases. Utilizing induced pluripotent stem cells, the company focuses on addressing significant unmet medical needs, particularly in conditions such as spinal muscular atrophy, amyotrophic lateral sclerosis, and Parkinson's disease. iPierian is engaged in the research and development of innovative therapies, including monoclonal antibodies aimed at treating Alzheimer's disease and other Tauopathies. By targeting the mechanisms that drive disease progression, the company aims to provide physicians with effective tools to slow the spread of Tau in the brain, thereby potentially improving patient outcomes.
SymBio Pharmaceuticals
Series B in 2006
SymBio Pharmaceuticals Limited is a biopharmaceutical company based in Tokyo, Japan, focused on the research, development, manufacturing, and marketing of pharmaceutical drugs, primarily in the fields of oncology and hematology. The company develops various anti-cancer agents, including Treakisym, which is used to treat non-Hodgkin's lymphoma, multiple myeloma, and chronic lymphocytic leukemia, and is currently undergoing Phase III trials for relapsed/refractory diffuse large B-cell lymphoma. Additionally, SymBio is working on several other drug formulations, including SyB L-1701, SyB L-1702, and Rigosertib SyB-C-0501, as well as SyB L-1101 and SyB C-1101 for higher-risk myelodysplastic syndromes. The company also has a candidate, SyB V-1901, aimed at treating infectious diseases. SymBio Pharmaceuticals operates primarily in Japan, South Korea, China, Hong Kong, Taiwan, and Singapore.
Cswitch
Series B in 2006
Cswitch specializes in developing system-on-a-chip semiconductors tailored for networking-based platforms. Founded by a team of experienced semiconductor executives, the company leverages their extensive background in advanced processors and ASIC development to create innovative configurable solutions. In addition to semiconductors, Cswitch provides design tools for configurable switch array devices and offers development and validation boards that facilitate the design and verification of various networking applications. Their focus spans multiple markets, including networking, telecommunications, storage, and wireless base stations, enabling them to address a wide range of industry needs.
A8 New Media Group
Series B in 2005
A8 New Media Group is an investment holding company based in Shenzhen, China, primarily engaged in digital entertainment services. The company operates through two main segments: Digital Entertainment and Property Investment. In the Digital Entertainment segment, A8 New Media Group provides a range of services, including music-based entertainment, film and television production, and game-related services. It sources music content from both domestic and international record labels and distributes it as ringtones, full track songs, and interactive voice response music. The company also develops computer software and social networking applications, and offers technical and management consultancy services. The Property Investment segment focuses on acquiring properties for rental and management fee income. Established in 2000, A8 New Media Group was previously known as A8 Digital Music Holdings Limited and rebranded in 2014.
Cohesive Technologies
Series B in 2003
Cohesive Technologies Inc. designs, manufactures, and markets breakthrough liquid chromatography (LC) solutions for the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company has developed patented technologies and a wide range of chromatographic products designed to significantly improve productivity by accelerating the separation, purification, and analysis of molecules in bioanalysis. With a strong depth of knowledge in column chemistry, applications, engineering, software development, and quality management, Cohesive Technologies leads the industry in the research, development, and production of LC technologies that accelerate the pace of customers' drug discovery and development efforts.
ObjectVideo
Series B in 2001
ObjectVideo, Inc. specializes in intelligent video analytics software designed for security, public safety, business intelligence, and process improvement applications. The company offers two main products: ObjectVideo OnBoard, which integrates analytics directly into cameras and other devices, and ObjectVideo VEW, which identifies and alerts users to specific events such as perimeter breaches and loitering. By converting video into actionable data, ObjectVideo's software supports a range of applications including facility security, asset monitoring, and loss prevention across various sectors such as transportation, education, banking, retail, and gaming. The company collaborates with a network of video intelligent partners, including OEMs and integrators, to market its solutions. ObjectVideo serves a diverse clientele, including government agencies and infrastructure sectors, and has its headquarters in Reston, Virginia. Founded in 1998, the company was previously known as DiamondBack Vision, Inc. before rebranding in 2001.
Dejima
Series B in 2000
Dejima is a software developer based in San Jose, California, with subsidiaries in Paris and Tokyo, established in 1998. The company specializes in natural interaction software that facilitates user engagement with computerized content using everyday language, eliminating the need for complex codes, commands, or menus. Its flagship product, Dejima Direct, allows users to request information and perform productivity tasks through various communication channels, including email, wireless messaging, the web, and speech. This technology is designed to make applications and databases more accessible by enabling users to interact in their preferred language, thereby bridging the gap between end users and digital systems.
eBags.com
Series B in 1999
eBags, Inc. is a prominent online retailer specializing in a diverse range of bags and travel accessories catering to various lifestyles. Founded in 1999 and based in Greenwood Village, Colorado, eBags offers an extensive selection of products, including luggage, travel bags, handbags, backpacks, and fashion accessories such as cosmetic bags and wallets. The company features products for all demographics, including men, women, and children, and provides items designed for travel, fitness, and outdoor activities. eBags partners with well-known brands like Samsonite, JanSport, and The North Face, ensuring a broad selection of premium products. Committed to exceptional customer service, eBags offers personalized assistance and real-time order tracking to enhance the shopping experience. As of 2017, eBags operates as a subsidiary of Samsonite LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.